LIGAND PHARMACEUT…
USUSDLIGAND PHARMACEUTICALS INC (US:LGND) — Biotechnology: Pharmaceutical Preparations. Количество бирж, на которых торгуются акции компании: 1. На этой странице — цена и график, дивиденды, крупнейшие держатели и история количества акций.
О компании
- Сайт
- ligand.com
- Сектор
- Health Care · Biotechnology: Pharmaceutical Preparations
- Штаб-квартира
- SAN DIEGO, United States
- Генеральный директор
- Mr. Todd C. Davis Ph.D.
- Сотрудники
- 47
- Акций в обращении
- 19.94 млн на 2026-08-04
- Свободное обращение
- 19.48 млн
- Отрасль (SIC)
- Pharmaceutical Preparations
Описание
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
Биржи и тикеры
| Биржа | Тикер | Валюта | Цена | Тип |
|---|---|---|---|---|
| US USA Stocks | LGND | USD | 295 +0.59% | обыкновенные акции |
Дивиденды
Выплаты дивидендов не обнаружены (проверено 09.10.2026). Компания, вероятно, не выплачивает дивиденды.
Новости этой недели
Новостей с сайта компании пока нет.
Крупнейшие держатели
| Держатель | Доля | Акции | Дата отчета |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Van… | 0% | 395 811 | 2026-06-30 |
| Sterling Capital Managem… | 0% | 23 | 2026-06-30 |
